Vaibhav Global Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 5:35 pm

Quick Insight

Vaibhav Global Ltd, a player in the Retail – Apparel/Accessories sector, currently trades at a price of 208 with a market capitalization of 3,464 Cr. The company's P/E stands at 21.2, indicating a reasonable valuation, while ROE and ROCE at 11.7% and 14.0% respectively reflect decent profitability and capital efficiency. With an OPM of 8% and a Net Profit of 153 Cr, the company shows stability in its operations. The healthy reserves of 1,317 Cr provide a cushion, although the borrowing of ₹228 Cr and CCC of 181 days warrant monitoring. The P/BV ratio of 2.70x and ICR of 21.23x suggest a balanced financial position. In conclusion, Vaibhav Global's financial metrics present a mixed picture, signaling the need for a closer examination of its operational efficiency and leverage levels to make informed investment decisions.

Competitors of Vaibhav Global Ltd

All Competitor Stocks of Vaibhav Global Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:35 am

Below is a detailed analysis of the quarterly data for Vaibhav Global Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 814.00 Cr.. The value appears to be declining and may need further review. It has decreased from 850.00 Cr. (Mar 2025) to 814.00 Cr., marking a decrease of 36.00 Cr..
• For Expenses, as of Jun 2025, the value is 752.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 788.00 Cr. (Mar 2025) to 752.00 Cr., marking a decrease of 36.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 62.00 Cr..
• For OPM %, as of Jun 2025, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Mar 2025) to 8.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 5.00 Cr..
• For Tax %, as of Jun 2025, the value is 18.00%. The value appears to be increasing, which may not be favorable. It has increased from 17.00% (Mar 2025) to 18.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2025) to 38.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.26. The value appears strong and on an upward trend. It has increased from 2.05 (Mar 2025) to 2.26, marking an increase of 0.21.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:47 pm

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: July 25, 2025, 2:07 pm

Below is a detailed analysis of the balance sheet data for Vaibhav Global Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 33.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,317.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,225.00 Cr. (Mar 2024) to 1,317.00 Cr., marking an increase of 92.00 Cr..
• For Borrowings, as of Mar 2025, the value is 228.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 218.00 Cr. (Mar 2024) to 228.00 Cr., marking an increase of 10.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 456.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 405.00 Cr. (Mar 2024) to 456.00 Cr., marking an increase of 51.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,034.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,881.00 Cr. (Mar 2024) to 2,034.00 Cr., marking an increase of 153.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 566.00 Cr.. The value appears to be declining and may need further review. It has decreased from 616.00 Cr. (Mar 2024) to 566.00 Cr., marking a decrease of 50.00 Cr..
• For CWIP, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 5.00 Cr..
• For Investments, as of Mar 2025, the value is 116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 128.00 Cr. (Mar 2024) to 116.00 Cr., marking a decrease of 12.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,342.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,131.00 Cr. (Mar 2024) to 1,342.00 Cr., marking an increase of 211.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,034.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,881.00 Cr. (Mar 2024) to 2,034.00 Cr., marking an increase of 153.00 Cr..

Notably, the Reserves (1,317.00 Cr.) exceed the Borrowings (228.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

No data available for the No. of Shareholders chart.

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Vaibhav Global Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 9.25. This value is within the healthy range. It has increased from 7.74 (Mar 24) to 9.25, marking an increase of 1.51.
• For Diluted EPS (Rs.), as of Mar 25, the value is 9.10. This value is within the healthy range. It has increased from 7.59 (Mar 24) to 9.10, marking an increase of 1.51.
• For Cash EPS (Rs.), as of Mar 25, the value is 15.37. This value is within the healthy range. It has increased from 13.30 (Mar 24) to 15.37, marking an increase of 2.07.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.27. It has increased from 76.01 (Mar 24) to 81.27, marking an increase of 5.26.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.27. It has increased from 76.01 (Mar 24) to 81.27, marking an increase of 5.26.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 203.45. It has increased from 183.71 (Mar 24) to 203.45, marking an increase of 19.74.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 19.10. This value is within the healthy range. It has increased from 17.83 (Mar 24) to 19.10, marking an increase of 1.27.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.95. This value is within the healthy range. It has increased from 12.19 (Mar 24) to 12.95, marking an increase of 0.76.
• For PBT / Share (Rs.), as of Mar 25, the value is 12.05. This value is within the healthy range. It has increased from 10.99 (Mar 24) to 12.05, marking an increase of 1.06.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 9.22. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 9.22, marking an increase of 1.56.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 9.23. This value is within the healthy range. It has increased from 7.73 (Mar 24) to 9.23, marking an increase of 1.50.
• For PBDIT Margin (%), as of Mar 25, the value is 9.38. This value is below the healthy minimum of 10. It has decreased from 9.70 (Mar 24) to 9.38, marking a decrease of 0.32.
• For PBIT Margin (%), as of Mar 25, the value is 6.36. This value is below the healthy minimum of 10. It has decreased from 6.63 (Mar 24) to 6.36, marking a decrease of 0.27.
• For PBT Margin (%), as of Mar 25, the value is 5.92. This value is below the healthy minimum of 10. It has decreased from 5.98 (Mar 24) to 5.92, marking a decrease of 0.06.
• For Net Profit Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 5. It has increased from 4.16 (Mar 24) to 4.53, marking an increase of 0.37.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 8. It has increased from 4.20 (Mar 24) to 4.53, marking an increase of 0.33.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.36. This value is below the healthy minimum of 15. It has increased from 10.17 (Mar 24) to 11.36, marking an increase of 1.19.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.78. This value is within the healthy range. It has increased from 14.77 (Mar 24) to 14.78, marking an increase of 0.01.
• For Return On Assets (%), as of Mar 25, the value is 7.51. This value is within the healthy range. It has increased from 6.77 (Mar 24) to 7.51, marking an increase of 0.74.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.08.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.72. It has increased from 1.65 (Mar 24) to 1.72, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 2.37. This value is within the healthy range. It has increased from 2.33 (Mar 24) to 2.37, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 1.18. This value is within the healthy range. It has decreased from 1.19 (Mar 24) to 1.18, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 4. It has increased from 0.51 (Mar 24) to 0.57, marking an increase of 0.06.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 77.56 (Mar 24) to 0.00, marking a decrease of 77.56.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 44.83 (Mar 24) to 0.00, marking a decrease of 44.83.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 22.44 (Mar 24) to 0.00, marking a decrease of 22.44.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 55.17 (Mar 24) to 0.00, marking a decrease of 55.17.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 21.23. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 21.23, marking a decrease of 3.96.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.25. This value is within the healthy range. It has decreased from 12.51 (Mar 24) to 11.25, marking a decrease of 1.26.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,625.06. It has decreased from 6,037.66 (Mar 24) to 3,625.06, marking a decrease of 2,412.60.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.99 (Mar 24) to 1.07, marking a decrease of 0.92.
• For EV / EBITDA (X), as of Mar 25, the value is 11.43. This value is within the healthy range. It has decreased from 20.46 (Mar 24) to 11.43, marking a decrease of 9.03.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.98 (Mar 24) to 1.08, marking a decrease of 0.90.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 22.43 (Mar 24) to 0.00, marking a decrease of 22.43.
• For Price / BV (X), as of Mar 25, the value is 2.70. This value is within the healthy range. It has decreased from 4.80 (Mar 24) to 2.70, marking a decrease of 2.10.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.98 (Mar 24) to 1.08, marking a decrease of 0.90.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness